Telehealth executives accused of $100m Adderall scheme
The pandemic-era start-up distributed 40m pills of controlled substances "for no legitimate medical purpose".
British Broadcasting CorporationWatchRegisterSign InHomeNewsSportBusinessInnovationCultureTravelEarthVideoLiveHomeNewsIsrael-Gaza WarWar in UkraineUK General ElectionUS & CanadaUKUK PoliticsEnglandN. IrelandN. Ireland PoliticsScotlandScotland PoliticsWalesWales PoliticsAfricaAsiaChinaIndiaAustraliaEuropeLatin AmericaMiddle EastIn PicturesBBC VerifySportBusinessFuture of BusinessTechnology of BusinessWork CultureInnovationTechnologyScience & HealthArtificial IntelligenceCultureFilm & TVMusicArt & DesignStyleBooksEntertainment NewsTravelDestinationsAfricaAntarcticaAsiaAustralia and PacificCaribbean & BermudaCentral AmericaEuropeMiddle EastNorth AmericaSouth AmericaWorld’s TableCulture & ExperiencesAdventuresThe SpeciaListEarthNatural WondersWeather & ScienceClimate SolutionsSustainable BusinessGreen LivingVideoLiveLive NewsLive SportHomeNewsSportBusinessInnovationCultureTravelEarthVideoLiveAudioWeatherNewslettersTelehealth executives accused of $100m Adderall scheme13 hours agoBy Max Matza, BBC NewsShareGetty ImagesUS investigators have arrested the founder and CEO of a telehealth company who is accused of a running a $100m (£78m) scheme to fraudulently distribute over 40m pills of Adderall and other controlled substances.
US Attorney General Merrick Garland said that Done CEO Ruthia He conspired with the company's clinical president, David Brody, "to provide easy access to Adderall and other stimulants for no legitimate medical purpose".
America's top law officer said the executives had exploited telemedicine rules that were loosened during the Covid pandemic.
Done Global, a San Francisco-based start-up, became popular during the pandemic as an online way to obtain Adderall by paying a monthly subscription fee.
Ms He was arrested in Los Angeles and Dr Brody in San Rafael, California, according to officials.
https://www.bbc.com/news/articles/cd11qr67qj6o
Rating: 5